Hypothermia for Severe TBI, RAS Inhibitors After TAVR, OAC-PPI Therapy and UGIB, and more

Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the December 04, 2018 issue